Compare ANPA & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ANPA | DRTS |
|---|---|---|
| Founded | 2016 | 2015 |
| Country | Hong Kong | Israel |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 300.0M | 300.2M |
| IPO Year | 2025 | N/A |
| Metric | ANPA | DRTS |
|---|---|---|
| Price | $22.50 | $4.23 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 15.7K | ★ 78.3K |
| Earning Date | 09-30-2025 | 11-20-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $5,832,684.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $390.11 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.80 | $2.30 |
| 52 Week High | $54.75 | $4.69 |
| Indicator | ANPA | DRTS |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 60.27 |
| Support Level | N/A | $3.84 |
| Resistance Level | N/A | $4.28 |
| Average True Range (ATR) | 0.00 | 0.28 |
| MACD | 0.00 | 0.05 |
| Stochastic Oscillator | 0.00 | 76.64 |
Rich Sparkle Holdings Ltd is financial printing and corporate services provider which engaged in designing and printing financial print materials in Hong Kong. It service portfolio covers a myriad of deliverables, mainly including listing documents, financial reports, fund documents, circulars and announcements. The company's core business includes (i) financial printing services such as printing, typesetting and translation, (ii) advisory services including Environmental, Social and Governance Report and (iii) other services. Key revenue is generated from Financial printing services.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.